Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAs in rat small intestine

Drug Metabolism and Disposition

Volumn 31, Issue 10, 2003, Pages 1235-1239

  Takara, Kohji ^a   Ohnishi, Noriaki ^a   Horibe, Sayo ^a   Yokoyama, Teruyoshi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A; CYTOCHROME P450 3A1; CYTOCHROME P450 3A2; CYTOCHROME P450 CYP3A18; CYTOCHROME P450 CYP3A9; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG METABOLISM; DUODENUM; LIVER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; ATP-BINDING CASSETTE TRANSPORTERS; CYTOCHROME P-450 CYP3A; GENE EXPRESSION PROFILING; INTESTINE, SMALL; MALE; OXIDOREDUCTASES, N-DEMETHYLATING; P-GLYCOPROTEIN; P-GLYCOPROTEINS; RATS; RATS, WISTAR; RNA, MESSENGER;

ANIMALIA; RATTUS NORVEGICUS; STAPHYLOCOCCUS PHAGE 3A;

EID: 0141569628     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.10.1235     Document Type: Article

References (30)

1. Borst P, Schinkel AH, Smit JJ, Wagenaar E, Van Deemter L, Smith AJ, Eijdems EW, Baas F, and Zaman GJ (1993) Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. Pharmacol Ther 60:289-299.
2. Chiba M, Hensleigh M, and Lin JH (1997) Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A. Biochem Pharmacol 53:1187-1195.
3. de Waziers I, Cugnenc PH, Yang CS, Leroux JP, and Beaune PH (1990) Cytochrome P 450 isoemymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 253:387-394.
4. Ding X and Kaminsky LS (2003) Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149-173.
5. Fromm MF (2002) The influence of MDRI polymorphisms on P-glycoprotein expression and function in humans. Adv Drug Deliv Rev 54:1295-1310.
6. Gonzalez FJ, Nebert DW, Hardwick JP, and Kasper CB (1985) Complete cDNA and protein sequence of a pregnenolone 16 α-carbonitrile-induced cytochrome P-450. A representative of a new gene family. J Biol Chem 260:7435-7441.
7. Gonzalez FJ, Song BJ, and Hardwick JP (1986) Pregnenolone 16 α-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation. Mol Cell Biol 6:2969-2976.
8. Gushchin GV, Gushchin MI, Gerber N, and Boyd RT (1999) A novel cytochrome P450 3A isoenzyme in rat intestinal microsomes. Biochem Biophys Res Commun 255:394-398.
9. Hoen PA, Commandeur JN, Vermeulen NP, Van Berkel TJ, and Bijsterbosch MK (2000) Selective induction of cytochrome P450 3A1 by dexamethasone in cultured rat hepatocytes: analysis with a novel reverse transcriptase-polymerase chain reaction assay section sign. Biochem Pharmacol 60:1509-1518.
10. Kaminsky LS and Fasco MJ (1991) Small intestinal cytochromes P450. Crit Rev Toxicol 21:407-422.
11. Kayne LH, D'Argenio DZ, Meyer JH, Hu MS, Jamgotchian N, and Lee DB (1993) Analysis of segmental phosphate absorption in intact rats. A compartmental analysis approach. J Clin Investig 91:915-922.
12. Kirita S and Matsubara T (1993) cDNA cloning and characterization of a novel member of steroid-induced cytochrome P450 3A in rats. Arch Biochem Biophys 307:253-258.
13. Kolars JC, Schmiedlin-Ren P, Dobbins WO 3rd, Schuetz J, Wrighton SA, and Watkins PB (1992) Heterogeneity of cytochrome P450IIIA expression in rat gut epithelia. Gastroenterology 102:1186-1198.
14. Komori M and Oda Y (1994) A major glucocorticoid-inducible P450 in rat liver is not P450 3A1. J Biochem (Tokyo) 116:114-120.
15. Lin JH (2003) Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Adv Drug Deliv Rev 55:53-81.
16. Mahnke A, Strotkamp D, Roos PH, Hanstein WG, Chabot GG, and Nef P (1997) Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch Biochem Biophys 337:62-68.
17. Miksys SL and Tyndale RF (2002) Drug-metabolizing cytochrome P450s in the brain. J Psychiatry Neurosci 27:406-415.
18. Nagata K, Murayama N, Miyata M, Shimada M, Urahashi A, Yamazoe Y, and Kato R (1996) Isolation and characterization of a new rat P450 (CYP3AI8) cDNA encoding P450(6)β-2 catalyzing testosterone 6 β- and 16 α-hydroxylations. Pharmacogenetics 6:103-111.
19. Robertson GR, Farrell GC, and Liddle C (1998) Sexually dimorphic expression of rat CYP3A9 and CYP3A18 genes is regulated by growth hormone. Biochem Biophys Res Commun 242:57-60.
20. Rowlands JC, Wang H, Hakkak R, Ronis MJ, Strobel HW, and Badger TM (2000) Chronic intragastric infusion of ethanol-containing diets induces CYP3A9 while decreasing CYP3A2 in male rats. J Pharmacol Exp Ther 295:747-752.
21. Stephens RH, Tanianis-Hughes J, Higgs NB, Humphrey M, and Warhurst G (2002) Region-dependent modulation of intestinal permeability by drug efflux transporters: in vitro studies in mdr1a(-/-) mouse intestine. J Pharmacol Exp Ther 303:1095-1101.
22. Strotkamp D, Roos PH, and Hanstein WG (1995) A novel CYP3 gene from female rats. Biochim Biophys Acta 1260:341-344.
23. 1 cells. Biol Pharm Bull 26:205-209.
24. Takara K, Tsujimoto M, Ohnishi N, and Yokoyama T (2002) Digoxin up-regulates MDR1 in human colon carcinoma Caco-2 cells. Biochem Biophys Res Commun 292:190-194.
25. Takara K, Tsujimoto M, Ohnishi N, and Yokoyama T (2003b) Effects of continuous exposure to digoxin on MDR1 function and expression in Caco-2 cells. J Pharm Pharmacol 55:675-681.
26. Vos TA, Hooiveld GJ, Koning H, Childs S, Meijer DK, Moshage H, Jansen PL, and Muller M (1998) Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2 and the bile salt transporter. Spgp, in endotoxemic rat liver. Hepatology 28:1637-1644.
27. Wang H, Kawashima H, and Strobel HW (1996) cDNA cloning of a novel CYP3A from rat brain. Biochem Biophys Res Commun 221:157-162.
28. Watkins PB, Wrighton SA, Schuetz EG, Molowa DT, and Guzelian PS (1987) Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J Clin Investig 80:1029-1036.
29. Yokogawa K, Shimada T, Higashi Y, Itoh Y, Masue T, Ishizaki J, Asahi M, and Miyamoto K (2002) Modulation of mdr1a and CYP3A gene expression in the intestine and liver as possible cause of changes in the cyclosporin A disposition kinetics by dexamethasone. Biochem Pharmacol 63:777-783.
30. Zhang QY, Wikoff J, Dunbar D, and Kaminsky L (1996) Characterization of rat small intestinal cytochrome P450 composition and inducibility. Drug Metab Dispos 24:322-328.